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This review focuses on the mechanisms of DNA methylation, DNA
methylation pattern formation and their involvement in gene regula-
tion. Association of DNA methylation with imprinting, embryonic
development and human diseases is discussed. Furthermore, besides
considering changes in DNA methylation as mechanisms of disease,
the role of epigenetics in general and DNA methylation in particular in
transgenerational carcinogenesis, in memory formation and behavior
establishment are brought about as mechanisms based on the cellular
memory of gene expression patterns.
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Introduction
Cells differ from each other by express-
ing different combinations of genes at any-
one time. The combined product of these
genes eventually results in a set of morpho-
logical, biochemical and physiological char-
acteristics peculiar to a cell type and its
differentiation stage. Transcription factors
are crucial determinants in the acquisition
and maintenance of the pattern of gene ex-
pression shown by cells. They bind to de-
fined DNA sequences at the regulatory re-
gion of the genes and trigger events usually
associated with chromatin remodeling and
activation (or suppression) of gene trans-
cription. However, the number of transcrip-
tion factors present in a given cell is below
the amount necessary to produce enough
combinatorial products to define the spec-
trum of possibilities of gene expression within
a genome.
One element contributing to the cells’
ability to control wide expression of genes
by the genome with a limited number of
transcription factors is the stable inactiva-
tion of some genes during development or
along differentiation within a cell lineage.
Control of gene expression based only on
transcription factors would imply that gene
expression could be reversed by exposure of
the cell nucleus to a new set of transcription
factors. As a matter of fact, though many
aspects of gene expression can be repro-
grammed, some marks of differentiation
(meaning some expressed or silent genes)
are stable so that nuclear transplantation to
the cytoplasm of a different cell cannot
modify their availability for transcription.
These marks are not associated with somatic
mutations because there is no modification
in DNA sequence during cell differentiation
in vertebrates, with the notable exception of
sperm cells and lymphocytes (nucleated cells
with stable modifications of the genome tak-
ing place during differentiation).
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Epigenetics comprises mechanisms of
mitotic or meiotic inheritance which are not
the consequences of changes in DNA se-
quence. Epigenetic factors are chemically
stable and affect gene transcription, modify-
ing the phenotype with no corresponding
changes in the genotype (1). They could
suitably explain some differences between
monozygotic twins, for example in their sus-
ceptibility to diseases (2), even though this
hypothesis must take into account environ-
mental effects as modulators or inducers of
epigenetic factors. As we shall see later in
this review, this is slowly becoming recog-
nized, as more mechanisms and physiologi-
cal roles of epigenetics are unveiled.
There are at least three epigenetic mechan-
isms influencing animal development which
obeys the inheritability criteria: DNA me-
thylation, histone covalent modification and
the Polycomb-trithorax protein complexes.
In spite of the great importance of the
latter two and the probable interaction of the
three systems within the cell, in this review
we shall focus on the mechanisms associ-
ated with DNA methylation and their in-
volvement in cell differentiation, develop-
ment and cancer. The reader may find excel-
lent reviews on histone modification (1,3)
and on the Polycomb-trithorax system (4).
DNA methylation
Since its discovery in 1948, the fifth
DNA base - 5-methylcytosine (5-mC) - has
generated much controversy with respect to
its physiological significance. DNA cytosine
methylation is an epigenetic event because a
given methylation pattern may be inherited
by the daughter cells after a mitotic or mei-
otic division (2,5). Given its central impor-
tance in non-genomic inheritance and ear-
lier discovery, DNA methylation has been
named the “prima donna” of epigenetics (6).
DNA methylation in eukaryotic cells in-
volves the addition of a methyl group to the
carbon at position 5 of the cytosine ring.
This reaction is catalyzed by the enzyme
DNA methyltransferase (DNA-MTase) and
this methylation reaction is the most com-
mon covalent modification occurring in eu-
karyotic DNA.
DNA-MTases add methyl groups to cy-
tosine at the CG position (CpG, with p corre-
sponding to a phosphate group). The first
DNA-MTase gene was cloned from rats and
named Dnmt1. This gene is highly conserved
among eukaryotic organisms. The mamma-
lian DNA-MTase 1 (DNMT1) has high af-
finity for a hemimethylated substratum, but
is also able to add methyl groups to non-
methylated substrata de novo, thus creating
a methylation pattern which differs from
that observed in the mother cell (5,7,8).
Mutations in the mouse DNMT1 gene lead
to an increased deregulation of DNA methy-
lation and gene silencing, and are lethal to
the embryo (9). The de novo activity of the
mammalian DNMT1 seems to be stimulated
by aberrant DNA structures and by 5-mC in
only one strand of the DNA.
An evolutionary tendency is the loss of
CpG dinucleotides from the genome of higher
eukaryotic cells. It is possible that cytosine
methylation has played an important role in
this trend, because m-CpG dinucleotides are
easily deaminated to TpG (10), which makes
room for gene mutations, especially at hot
spots (11).
DNA methylation patterns in animals
DNA methylation in animals reaches a
wide spectrum of levels and patterns. At one
extreme is the nematoid Caenorhabiditis
elegans, which shows no 5-mC modifica-
tions as a result of the derivational loss of a
gene coding for the conventional DNA-
MTase (12). Drosophila melanogaster has a
DNA-MTase gene but exhibits low levels of
5-mC modification. The small amount of 5-
mC in D. melanogaster appears as m-CpT
instead of m-CpG, which occurs in most
other organisms. At the other extreme, the
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vertebrate genome has the highest levels of
5-mC found in the animal kingdom. DNA
methylation is dispersed throughout the ver-
tebrate genome in a pattern designated glo-
bal methylation.
In animal somatic cells, 5-mC represents
1% of the DNA bases and affects 60-90% of
the CpG dinucleotides in the genome (13).
In the rat, there is a 70% decrease in the
amount of DNA methylation within a short
period of the early development. Then de
novo methylation recovers the initial levels
during implantation. For the rat and prob-
ably for other mammals, the cycle of
demethylation and de novo methylation is
critical for the establishment of the methyla-
tion pattern in somatic cells. In mammalian
cells in culture, the efficiency in the mainte-
nance of the methylation pattern during cell
division is between 97 and 99.9%. De novo
methylation rates are about 3-5% per mito-
sis. Although very low, this de novo methy-
lation might cause modification of the epi-
genetic markers (2,14).
The most striking characteristic of the
DNA methylation patterns in vertebrates is
the presence of CpG islands (non-methylat-
ed CpG-rich regions) (15). Computer analy-
sis of the human genome has revealed the
presence of about 29,000 CpG islands (16)
and has shown that about 60% of the human
genes have associated CpG islands, most of
which remain non-methylated during devel-
opment in most tissues (17). Of this total,
70% are associated with human genes and
over half of them are located at the 5'-end of
genes and present a potential regulatory func-
tion through DNA methylation (18).
A primary effect of the environment on
DNA methylation patterns results from the
fact that the presence in the diet of methyl
group donors and co-factors, such as the
amino acid methionine, which are necessary
for the methylation reaction, influences the
overall methylation levels (19).
The methylation and demethylation reac-
tions during germ cell differentiation and then
soon after fecundation are extensively involved
in imprinting mechanisms. Imprinting refers
to the selective inactivation by DNA methyla-
tion in addition to other factors of a parent
specific allele. The setting of imprinting takes
place by a methylation wave occurring soon
after fecundation. The pattern of parental im-
printing is erased very early during germ cell
development so that alleles coming from the
parent of the opposite sex will then be set to
behave according to the sex of the individual.
Details of imprinting are found in many text-
books and a good overview is provided by
Lewin’s Genes VIII (20), including mechan-
isms involved in normal and abnormal im-
printing of IGF-2 (insulin-like growth factor II
gene) and its membrane receptor (IGF2R),
which are perhaps the most studied imprinted
genes. Besides details on imprinting, Hartl
and Jones (21) provide a discussion on DNA
methylation-dependent co-suppression mech-
anisms in plants that might be of interest to
plant biologists.
Lists of both human (cancer.otago.ac.nz/
IGC/Web/home.html) and mouse (www.
mgu.har.mrc.ac.uk/research/imprinting/)
imprinted genes are available in the World
Wide Web.
The origin of the CpG islands
As mentioned before, a CpG island is a
DNA sequence with a high incidence of
CpG dinucleotides which remains unmethyl-
ated after development or in differentiated
cells. A major issue in epigenetics is the
question of how such islands resist methyla-
tion.
The binding of a protein to the DNA
would sterically hinder the binding of a DNA-
MTase. If such protein was present at the
time of de novo methylation, then it could
contribute to the maintenance of that se-
quence as a non-methylated CpG island.
However, this possibility remains elusive
and such blocking protein has not been iden-
tified as yet. A second possibility for the
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maintenance of these non-methylated islands
would be the recognition of given chromatin
structures achieved by specific patterns of
histone covalent modifications (see below).
It is also possible that CpG islands ap-
pear by demethylation. Such demethylation
activity could take place through a thermo-
dynamically unfavorable break in the car-
bon-carbon bond joining the pyrimidine to
its methyl group or by a repair process
through the excision of the methylated 5-mC
and the addition of a cytosine. In plants, a
DNA glycosylase enzyme, named DEMETER,
removes the methyl groups of m-CpG (22).
However, there is no animal counterpart to
this enzyme, a fact that weakens this hypo-
thesis.
A small, though important, part of the
CpG islands becomes methylated during
development and, when this occurs, the gene
becomes stably silent. The programmed
methylation of the CpG islands during de-
velopment is involved in the imprinting of
the genome and inactivation of the X chro-
mosome (see below). De novo methylation
occurs in the embryonic germ cells, suggest-
ing high activity in this lineage, though so-
matic cells are also thought to be subjected
to methylation. A given fraction of the hu-
man CpG islands undergoes progressive
methylation after development in some tis-
sues and in cancer cells.
Origin of the methylation patterns,
their maintenance and loss
The mechanisms underlying the estab-
lishment of a given methylation pattern are
still unknown. However, it is already recog-
nized that the DNA-MTases DNMT3A and
DNMT3B are responsible for new methyla-
tion of the DNA (de novo methyltrans-
ferases). These enzymes are highly expressed
in young embryonic cells, during the period
when de novo methylation takes place. They
are essential for the embryonic development
of mice and mutations in the corresponding
human genes lead to mental retardation,
atypical craniofacial development and insta-
bility of the repetitive pericentromeric DNA
(5). How these enzymes identify the genome
regions to be methylated in each cell type is
still unknown.
One possibility is that the de novo methy-
lation occurring in mammalian cells at the
beginning of development does not discrimi-
nate the target genes, but will affect all avail-
able CpG. This default (or global) methyla-
tion is compatible with the fact that there is
no sequence in the mammalian genomes
which are intrinsically non-methylated. Even
some CpG islands, which most of the time
are non-methylated, may be methylated un-
der certain circumstances during normal or
tumoral development. It is also clear that not
every region of the genome is equally acces-
sible to the DNA-MTases. Particularly,
DNMT3B is known to be required for the de
novo methylation of specific genome re-
gions such as the repetitive pericentromeric
DNA and CpG islands in the inactive X
chromosome, indicating a preferential activ-
ity towards silent chromatin regions.
Evidence corroborating the idea that ac-
cessory factors are required for the proper
methylation arose from plants. In these or-
ganisms, an SNF-2-like chromatin remodel-
ing factor is essential for the complete me-
thylation of the Arabidopsis thaliana ge-
nome (23). Thus, one may assume that DNA
methylation requires a disturbance of the
chromatin structure by these remodeling fac-
tors, allowing the access of DNA-MTases to
the DNA. This sequence of events seems to
be particularly necessary for the activation
of genes in heterochromatic regions.
Another hypothesis to explain global
methylation is the fact that the methylation
machinery of mammals acts preferentially
on certain DNA sequences, particularly the
repetitive ones. The presence of high levels
of methylation at certain regions would func-
tion as a methylation center, thus spreading
the methylation to adjacent regions. Barriers
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to this spread would result in the formation
of CpG islands. A probable starting factor
for this methylation would be some DNA
repetitive sequences, even though it is not
known whether they correspond to direct or
indirect causes of methylation. The clearest
definition of a methylation center came from
studies on Neurospora (24).
New findings on the methylation of DNA
came from studies on the post-transcrip-
tional silencing of genes in plants. Double-
strand RNA triggers the destruction of cog-
nate transcripts and is the basis for the widely
diffused siRNA technology. There is a sug-
gestion that this process results in the methy-
lation of the corresponding DNA in the ge-
nome. The post-transcriptional silencing of
genes through double-strand RNA is an an-
cient mechanism of protection of the ge-
nome, occurring in fungi, plants and ani-
mals. However, these two processes are not
obligatorily related to each other, since si-
lencing is present in C. elegans in the com-
plete absence of 5-mC. The clear association
between double-strand RNA and gene si-
lencing through DNA methylation still re-
quires further investigation.
The maintenance of methylation patterns
depends on mechanisms that reproduce a
given methylation pattern along cell genera-
tions. A conceivable mechanism results from
the semi-conservative duplication of the
methylation pattern followed by the activity
of DNMT1, which adds methyl groups to the
new strand at the points where the parental
strand bears m-CpG (25). Through this mech-
anism, the pattern of methylation (i.e., meth-
ylated and non-methylated sequences) is
copied and the epigenetic information is
transferred along cell generations and also to
the organism’s next generation. In plants,
the enzyme DNA methyltransferase 1
(MET1), ortholog to the animal DMT1, ex-
hibits the same activity and consequently is
responsible for the imprinting observed in
these organisms (22).
The idea that new methylation patterns
are established at the beginning of develop-
ment by the DNMT3A and DNMT3B de
novo methyl transferase and then reproduced
in the somatic cells by the DNMT1 seems
appealing but cannot explain the preserva-
tion of methylation patterns during cell
proliferation. It was reported that cultured
tumor cells lacking DNMT1 activity
(DNMT1-/-) showed only a 20% reduction in
the level of genomic methylation during cul-
turing, as compared to normal cells. Though
detailed patterns of methylation are not pre-
served at the level of single CpG, the status
of methylation of DNA domains seems to be
propagated during development with high
efficiency. CpG islands preserve their meth-
ylated or non-methylated state in an ex-
tremely stable manner for several cell gen-
erations. DNMT1 is partially responsible for
this stability, but it is likely that additional
factors are involved in the preservation of
the methylation status of individual CpG
islands, since, as mentioned above, methyla-
tion patterns are preserved even in the ab-
sence of the only known maintenance meth-
yl transferase, DNMT1 (5).
There is still much debate about the pos-
sibility that loss of methylation would affect
genome integrity, as represented by bizarre
chromosomal rearrangements due to non-
homologous recombination and higher mu-
tation incidence in genes found in hypo-
methylated regions. New experimental evi-
dence will certainly direct this discussion.
For instance, deletion of DNMT3 resulted in
chromosomal instability and spontaneous
immortalization of mouse embryonic fibro-
blasts (26), reinforcing a role of DNA me-
thylation in genome integrity.
Gene silencing
DNA methylation causes changes in chro-
matin structure, modifying the interactions
between the DNA and activating or repress-
ing transcription factors (or complexes).
Could one assume that transcriptional
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inactivity would result in DNA methyla-
tion? Studies on the mechanisms for the
maintenance of CpG islands in a non-meth-
ylated state give support to this idea. The
coincidence between the location of CpG
islands and promotor regions is astonishing.
Further coincidence between the 5'-end of
the CpG island and the transcription factor
binding region is usually observed. The po-
tential importance of the promoter activity
and the genesis of the CpG island was dem-
onstrated by studies with transgenic mice.
Transgenes containing CpG islands usually
reproduce the non-methylated status, but their
resistance to methylation is lost if the pro-
moter activity is below normal, so that tran-
scriptional inactivity may lead to de novo
methylation.
It is not clear at present whether there is
some sort of signal from an inactive gene
that would result in silencing through DNA
methylation. One attractive possibility is that
chromatin structure may be informative to
the methylation machinery. Lysine acetyla-
tion at the histone tails by histone acetyl
transferases facilitates the access of trans-
cription factors to the gene. Histone dea-
cetylases (HDAC) reverse the process, re-
ducing the transcription rate of the gene
(27). It is worth mentioning at this point that
mutations in the HDAC genes may result in
cancer (1). This implies that the covalent
modifications of the core histones are inti-
mately associated with the transcriptional
activity and could be read by the methyla-
tion machinery. Studies in Neurospora, Dro-
sophila and other organisms have indicated
a clear association between histone methyla-
tion and DNA methylation, as particularly
shown by the demonstration that inactivat-
ing mutation in the gene of a histone methyl-
transferase [with activity towards Lys9 of
histone H3 (H3K9)] abolished genome me-
thylation. In mammals and in yeast, Lys9
methylation in histone H3 is associated with
transcriptionally repressed heterochromatin.
If DNA methylation in mammals is proven
to be dependent on histone methylation, the
idea that DNA methylation targets previ-
ously silenced genes will gain further sup-
port (28).
Jackson and colleagues (29), studying
DNA methylation in A. thaliana, observed
three possible methylation forms of Lys9 of
histone H3 (monomethylated, dimethylated
and trimethylated). Each form results from
the activity of the methyl transferase kryp-
tonite. Kryptonite mutations resulted in a
reduced rate of methylated CpNpG (N mean-
ing any base) and suppression of the silenc-
ing of genes SUPERMANn, TA3 and FWA,
besides the reactivation of transposable ele-
ments. These findings suggest that H3K9
methylation is associated with DNA methy-
lation also in plants. However, while H3K9
methylation is required for methylation of
all CpG sites in Neurospora, it is necessary
only for the methylation of CpNpG sites in
Arabidopsis.
Methylation of a CpG sequence at the
promoter region causes the binding of pro-
teins containing the methylated CpG-bind-
ing domain (MBD) and transcription sup-
pressors, such as HDAC, blocking the be-
ginning of transcription in mammals. In Neu-
rospora, methylation may also interrupt
transcription of a transcriptionally active gene
(15). Four of the five MBD already identi-
fied show transcription inhibition activity,
establishing complexes with HDAC, nucleo-
some remodeling proteins and transcription
repressors (30). MeCP2, an MBD, shows
affinity for hypermethylated DNA sequences
and may act by recruiting a transcription
repressor protein complex (1,5).
Non-methylated transgenes, retrotrans-
posons and repetitive DNA may have a dis-
ordered expression and could contribute to
genome destruction, suggesting that DNA
methylation has a defensive or protective
function (31).
Methylation of a previously silenced gene
would cause an irrevocable suppression. Me-
thylation clearly contributes to the stability
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of the inactivation, in events such as inacti-
vation of the X chromosome and retroviral
genes. On the other hand, demethylation
agents may reverse the methylation status of
the genome. Genes present in the inactive X
chromosome are reactivated in rat embry-
onic cells lacking DNA-MTases. Treatment
with 5-azacytidine, a demethylating agent,
also interferes with the imprinting observed
during X chromosome inactivation. 5-Aza-
cytidine is a potential antineoplastic drug
when hypermethylation is detected as a caus-
ative agent of tumor growth (32).
In addition to the above mentioned pos-
sibility that, besides degradation of the cor-
responding mRNA, double-strand RNA in-
troduction in a cell would also suppress the
expression of the corresponding gene through
DNA methylation, it was recently shown
that genes located downstream to the estro-
gen receptor activation, such as the proges-
terone receptor, become stably inactivated
and suppressed by DNA methylation in the
absence of estrogen stimulation (33). This
has a profound influence on mammary gland
cancer because later reintroduction of estro-
gen is not sufficient to reestablish expres-
sion of the progesterone receptor gene.
DNA methylation and diseases
Unusual methylation or demethylation
does affect the human phenotype, giving
rise to several syndromes and diseases. Many
diseases are now better understood in the
light of epigenetics, especially after the con-
sideration of the methylation status of genes
and genome. Centromere instability, facial
abnormalities, Rett syndrome, immunodefi-
ciency, autoimmunity, and neoplasias may
originate from abnormal methylation during
or after development (15).
Tzao and colleagues (34) investigated
the possible mechanisms involved in the
changes occurring in the fragile histone triad
gene (FHIT), a putative tumor suppressor
gene, in the genesis of lung neoplasias. FHIT
modifications are frequently found in lung
tumors. Besides, mutations in this gene are
also found in bronchial lesions in chronic
smokers, suggesting that FHIT deregulation
anticipates tumor development, appearing
very early during carcinogenesis. Fifty per-
cent of the patients with lung cancer showed
reduced FHIT protein, with a significant
correlation between the abnormal expres-
sion of protein and alternative splicing in
CpG islands at the 5'-end of the gene. This
reinforces the idea that DNA methylation
may be of diagnostic potential in lung and
other cancers.
The study of Oelke and colleagues (35)
showed that DNA hypomethylation contri-
butes to changes in gene expression and
function of T lymphocytes in systemic lupus
erythematosus. Treatment of T cells of nor-
mal donors with 5-azacytidine led to the
identification of methylation-sensitive genes.
The co-stimulatory molecule CD70, whose
overexpression results in the production of
polyclonal IgG in lupus patients, was identi-
fied as one of the important genes. T cells
treated with different demethylation drugs
resulted in increased CD70 mRNA and pro-
tein levels and caused an increase in the
secretion of IgG. This latter effect was re-
versed by treatment with anti-CD70 anti-
bodies. Despite these observations, the
demethylated sequences responsible for the
increased expression of CD70 have not been
identified.
DNA methylation has been implicated in
a series of hematological diseases and ef-
forts for the development of epigenetic drugs
and therapies are growing and will shortly
be successful in some areas (32,36).
Abnormal DNA methylation in
cancer: hypermethylation or
hypomethylation?
Promoter hypermethylation has been
pointed out as an important phenomenon dur-
ing cancer development (28). Methylation of
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sequences corresponding to genes coding for
components of the DNA repair system and
tumor suppressor genes is usual in different
tumors (37), and its importance in tumor de-
velopment is equivalent to that of gene muta-
tion and loss of heterozygosity (38).
A first assumption regarding the effect of
DNA hypomethylation is gene activation.
As a matter of fact, H-RAS, C-MYC, CT
genes (genes normally expressed in the tes-
tis and aberrantly activated in tumors),
MAGE in melanoma and CAGE in testis
cancer are activated by hypomethylation.
The gene products resulting from gene acti-
vation by DNA hypomethylation correspond
to cyclin D2 and maspin in gastric carcino-
ma, MN/CA9 in renal cell carcinoma,
S100A4 in colon cancer metastatic cells,
and in 14-3-3σ (among other proliferation-
associated proteins) in pancreatic cancer (36).
A second event resulting from DNA hy-
pomethylation in tumors is chromosomal
instability. De-repression of satellite se-
quences may result in non-homologous re-
combination and chromosomal alterations
(6). However, the chromosomal instability
appearing in tumors and related to hypo-
methylation is not global, but specific, re-
sulting in typical chromosomal rearrange-
ments, the most commonly found being t(1,6)
usually associated with Wilm’s tumor (39).
On the other hand, targets of hypermethyl-
ation are inactivated. To develop tumors,
these targets must be negative regulators of
cell cycle progression or positive regulators
of resistance to apoptosis. As a matter of
fact, the tumor suppressor genes P16, VHL,
RB, APC, and BRCA1 were found to be
silenced by DNA hypermethylation in one
or more tumors (36,40). Hypermethylation
of the CpG islands in the promoter region of
tumor suppressor genes has been proposed
as a diagnosing tool for lung and colorectal
neoplasias (30).
However, since most of the information
on DNA hypomethylation in cancer results
from the total amount of m-CpG, which may
not directly represent demethylation of regu-
latory m-CpG, and despite the knowledge of
hypomethylation target genes in tumors, there
is a prevalent idea that hypermethylation
and hypomethylation are not mutually ex-
clusive in cancer.
As mentioned above, imprinting is an
epigenetic mechanism that distinguishes al-
leles whose sequences are identical but that
were provided by each parent. The adaptive
advantage of imprinting genes is not cur-
rently clear, though several hypotheses exist
in attempts to explain it (41). Loss of im-
printing (LOI) implies biallelic expression
or suppression of genes that should be im-
printed. Wilm’s tumor is attributed to biallelic
expression of IGF-2 and suppression of H19.
The former seems to increase resistance to
apoptosis and the latter seems to result in
loss of growth suppressor elements. LOI
may occur in somatic as well as in germ
cells. Patients with germinal LOI exhibit the
Beckwith-Wiedmann syndrome and a higher
incidence of tumors, with 1000-fold the fre-
quency of non-affected individual.
LOI in chromosomes 19q and 9p are
related to oligodendrogliomas and childhood
acute lymphoblastic leukemias, respectively
(36).
Transgenerational carcinogenesis repre-
sents an additional step in the complexity of
the involvement of DNA methylation in can-
cer development. Transgenerational carci-
nogenesis corresponds to the transmission
of tumor susceptibility to the progeny by
parents exposed to carcinogens before mat-
ing. In an experimental model (42), expo-
sure to chromium (III) affected DNA methy-
lation in sperm cells, with increased hypo-
methylation effects on the 45S ribosomal
genes. The treatment also resulted in a prog-
eny of individuals larger than the parents
and with increased T3 levels. Microarray
analysis of the liver in the progeny revealed
that genes involved in tumor growth/sup-
pression were affected, potentially increas-
ing the possibility of tumor development.
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Though appearing as a proposed mechanism
and based only on a few experimental mod-
els, the inheritability of environmentally in-
duced epigenetic markers must be consid-
ered as an appealing possibility to explain
the high incidence of cancer in these indi-
viduals that cannot be attributed solely to
germ cell mutation (43).
Memories: remembering Mom’s
sweet embrace
Epigenetic mechanisms have been iden-
tified in neuron development and synapse
formation. Neuronal exclusive expression
of neuron-specific genes is controlled by
epigenetic mechanism mainly associated with
histone modification. RE-1 silencing trans-
cription factor (REST) is a transcription fac-
tor which binds to and blocks a neuron-
restrictive silencer element found in the pro-
moter region of neuron-specific genes. REST
expression and function blocks the expres-
sion of neuron-specific genes in non-neu-
ronal cells. After binding to the neuron-
restrictive silencer element, REST recruits
co-factors, histone acetylases and histone
methyltransferases, resulting in overall reor-
ganization of the local chromatin (44). In-
volvement of DNA methylation in this pro-
cess has not been characterized as yet. Since
histone covalent modifications as an epige-
netic mechanism are not the focus of the
present review, we will direct the reader to a
recent review on the epigenetic mechanisms
controlling memory formation, human cog-
nition development and impairment in some
neurodegenerative diseases (45) and con-
centrate the discussion on other aspects of
neurobiology in which DNA methylation
plays a controversial central role.
Schizophrenia is a serious disorder re-
sulting in patient inability to deal with daily
social situations and difficulties in perform-
ing simple cognitive tasks. The etiology of
schizophrenia has been correlated with defi-
ciency of an extracellular matrix protein
named reelin by a growing body of evidence
(46). Inhibitors of either HDAC or DNMTs
increase reelin expression, indicating their
regulation by histone acetylation and DNA
methylation (46,47).
DNA methylation and associated control
have been implicated in Rett’s syndrome, a
disease responsible for most of the intellec-
tual disabilities observed in girls. This syn-
drome results from germline mutations in
MeCP2 and the disease is suggestively asso-
ciated with the derepression of genes nor-
mally suppressed by methylation. Since there
is no general gene derepression, it is thought
that MeCP2 might function in the control of
specific genes associated with neural devel-
opment and function (48).
Rat behavior and response to stress have
long been known to be modulated by aspects
of maternal guarding during the first week of
lactation. This effect is not dependent on the
genome, because foster mothers elicit a less
fearful and more modest hypothalamic-pitu-
itary-adrenal response to stress in their prog-
eny with licking and grooming activities
(49). Weaver and colleagues (50) have
mapped this phenomenon to the expression
levels of the glucocorticoid receptor gene in
the hippocampus and have demonstrated that
DNA methylation and other factors are in-
volved in the epigenetic regulation of the
expression levels of the glucocorticoid re-
ceptor gene. They also observed that the
phenomenon is affected by central infusion
of a histone deacetylase inhibitor.
A general conclusion based on the pres-
ent review is that epigenetics is an important
adaptive factor allowing the offspring to
adapt to subtle changes in the environment
detected through modifications in parental
behavior.
It is worth stressing that DNA methylation
appears to be an epigenetic mechanism allow-
ing the perpetuation of an acquired behavior
across generations and that de novo methyla-
tion occurs during the early postnatal period.
Since the only genes currently known to be de
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novo methylated during the postnatal period
are the glucocorticoid receptor gene mentioned
above and the Hoxa5 and Hoxb5 genes (51), it
remains to be determined whether this is a
general or specific event.
It is tempting to ask whether imprinting
at the molecular level would correlate with
androgen and/or estrogen imprinting in the
hypothalamus which also occurs during the
first days after birth and controls sexual
behavior after puberty in rats (52-54).
We conclude that the primordial func-
tion of de novo methylation is the generation
of a memory of the gene expression pattern
established in embryos throughout later de-
velopment and adulthood, including defini-
tion of imprinting patterns. An emerging
function is the physiological role in keeping
the structural stability of chromosomes and
their normal behavior during mitotic and
meiotic cell divisions.
The molecular mechanisms generating
the methylation patterns are still poorly un-
derstood. Uncertain are also the mechan-
isms preserving the CpG island in a non-
methylated state and how the rest of the
DNA is methylated.
However, increasing knowledge about
the current involvement of epigenetics in
general, and DNA methylation in particular,
in human diseases has brought such phe-
nomena to center stage in biomedical re-
search. It became clear that methylation is
not a primary event in gene silencing, but
usually takes place in genes previously re-
pressed by other mechanisms. Besides, it is
possible that different epigenetic mechan-
isms act in concert at different developmen-
tal stages, defining the memory of complex
patterns of gene expression.
Finally, we can predict that the impor-
tance of events regulated by DNA methyla-
tion and the development of tools such as
methylation-sensitive representational dif-
ference analysis (55,56) and epigenetic drugs
(32,57) will certainly encourage the study of
the epigenome.
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